Idarubicin, Cytarabine and Pravastatin As Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

被引：1
|
作者：
Shadman, Mazyar [1 ,2 ]
Mawad, Raya [3 ]
Dean, Carol [1 ]
Shannon-Dorcy, Kathleen [1 ]
Sandhu, Vicky [1 ]
Hendrie, Paul C. [2 ]
Scott, Bart L. [1 ,2 ]
Walter, Roland B. [1 ,2 ]
Becker, Pamela S. [1 ,2 ]
Pagel, John [1 ,2 ]
Estey, Elihu H. [2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Swedish Med Ctr, Seattle, WA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.3732.3732
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome
    Shadman, Mazyar
    Mawad, Raya
    Dean, Carol
    Chen, Tara L.
    Shannon-Dorcy, Kathleen
    Sandhu, Vicky
    Hendrie, Paul C.
    Scott, Bart L.
    Walter, Rol B.
    Becker, Pamela S.
    Pagel, John M.
    Estey, Elihu H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (06) : 483 - 486
  • [2] Venetoclax Combined with Cladribine, Idarubicin, Cytarabine (CLIA) As Induction Therapy in Patients with Newly Diagnosed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
    Reville, Patrick K.
    Kantarjian, Hagop
    Borthakur, Gautam
    Yilmaz, Musa
    Daver, Naval
    Short, Nicholas
    DiNardo, Courtney D.
    Kornblau, Steven M.
    Pemmaraju, Naveen
    Jain, Nitin
    Alvarado, Yesid
    Bose, Prithviraj
    Jabbour, Elias
    Chien, Kelly S.
    Abbas, Hussein A.
    Masarova, Lucia
    Wang, Sa A.
    Tidwell, Rebecca S. S.
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Konopleva, Marina
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD, 2022, 140 : 1702 - 1704
  • [3] Cladribine, Idarubicin, Cytarabine (araC), and Venetoclax in Treating Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
    Reville, Patrick K.
    Kantarjian, Hagop M.
    Borthakur, Gautam
    Yilmaz, Musa
    Montalban-Bravo, Guillermo
    DiNardo, Courtney D.
    Andreeff, Michael
    Daver, Naval
    Jain, Nitin
    Kornblau, Steven M.
    Jabbour, Elias
    Short, Nicholas J.
    Alvarado, Yesid
    Ohanian, Maro
    Bose, Prithviraj
    Masarova, Lucia
    Wang, Sa A.
    Tidwell, Rebecca S. S.
    Estrov, Zeev E.
    Garcia-Manero, Guillermo
    Konopleva, Marina
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD, 2020, 136
  • [4] Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome
    Lee, ST
    Jang, JH
    Suh, HC
    Hahn, JS
    Ko, YW
    Min, YH
    AMERICAN JOURNAL OF HEMATOLOGY, 2001, 68 (04) : 237 - 245
  • [5] Combination of decitabine, idarubicin, cytarabine, and G-CSF (DIAG) regimen for the treatment of high-risk myelodysplastic syndrome and acute myeloid leukemia
    Xueya Zhang
    Xizhe Guo
    Annals of Hematology, 2019, 98 : 2223 - 2225
  • [6] Combination of decitabine, idarubicin, cytarabine, and G-CSF (DIAG) regimen for the treatment of high-risk myelodysplastic syndrome and acute myeloid leukemia
    Zhang, Xueya
    Guo, Xizhe
    ANNALS OF HEMATOLOGY, 2019, 98 (09) : 2223 - 2225
  • [7] A Phase II Trial of Venetoclax in Combination with Cladribine, Idarubicin, and Cytarabine in Newly Diagnosed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
    Bouligny, Ian M.
    Kantarjian, Hagop M.
    Yilmaz, Musa
    Daver, Naval
    Borthakur, Gautam
    Dinardo, Courtney D.
    Montalban-Bravo, Guillermo
    Short, Nicholas J.
    Valero, Yesid Alvarado
    Jabbour, Elias
    Jain, Nitin
    Pemmaraju, Naveen
    Hammond, Danielle
    Chien, Kelly S.
    Takahashi, Koichi
    Issa, Ghayas C.
    Abbas, Hussein A.
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD, 2024, 144 : 735 - 736
  • [8] Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome.
    Lee, ST
    Hahn, JS
    Ko, YW
    Min, YH
    BLOOD, 2001, 98 (11) : 215B - 215B
  • [9] Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine
    Wiedower, Eric
    Jamy, Omer
    Martin, Michael G.
    ANTICANCER RESEARCH, 2015, 35 (11) : 6287 - 6290
  • [10] Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia
    Hofmann, WK
    Heil, G
    Zander, C
    Wiebe, S
    Ottmann, OG
    Bergmann, L
    Hoeffken, K
    Fischer, JT
    Knuth, A
    Kolbe, K
    Schmoll, HJ
    Langer, W
    Westerhausen, M
    Koelbel, CB
    Hoelzer, D
    Ganser, A
    ANNALS OF HEMATOLOGY, 2004, 83 (08) : 498 - 503
12345